Setting Up a Tablet & Capsule Manufacturing Unit in Nigeria: MSME Guide

Pharmaceutical manufacturing, especially in tablets and capsules, plays a critical role in healthcare accessibility and economic development. In Nigeria, where demand for quality medication continues to rise, setting up a local Tablet and Capsule Manufacturing Business in Nigeria can be both a socially impactful and financially rewarding venture. For MSMEs, this industry offers scalable entry points, supported by growing policy focus on local drug production and import substitution.

Why Tablet & Capsule Manufacturing Matters in Nigeria

Tablet and capsule production is a major part of the pharmaceutical sector. In Nigeria, this matters more than ever. The country currently imports over 70% of its medicines, which creates both a dependency on foreign suppliers and higher costs for local consumers. But demand is rising – driven by a growing population, urbanization, and increasing awareness of health and wellness.

In 2024, Nigeria’s pharmaceutical market was estimated to be worth over ₦1.5 trillion, and it’s expected to grow further with support from government policies that encourage local production. For instance, initiatives by NAFDAC (National Agency for Food and Drug Administration and Control) are simplifying licensing for local drug manufacturers to reduce reliance on imports.

For small and medium enterprises (MSMEs), this industry is becoming more accessible. The setup doesn’t always need a massive investment, especially if you start with basic formulations and a narrow product range. Government-backed funds and industrial parks in states like Lagos, Ogun, and Anambra are helping businesses access land, power, and logistics at lower costs.

Local manufacturing also means faster supply during medical emergencies and better control over product quality. And because tablets and capsules are widely used across treatments – from malaria to hypertension – there’s year-round demand.

Industry Overview

Tablet and capsule manufacturing is at the heart of Nigeria’s pharmaceutical sector. These solid dosage forms are the most commonly used medications, not just in hospitals and pharmacies, but also for over-the-counter sales. Their popularity comes from being easy to swallow, stable during transport, and simple to store—even in hot climates like Nigeria’s.

With Nigeria aiming to reduce drug imports and increase local pharmaceutical production by 40% by 2026 (according to national policy goals), there’s a growing focus on setting up well-regulated tablet and capsule units within the country. These units are becoming more modern, often adopting semi-automated systems to keep costs low while maintaining quality.

Key Products

1. Tablets:
These come in various types, including:

• Plain tablets – simple, uncoated, often for fast action
• Film-coated tablets – for better taste and longer shelf life
• Chewable tablets – mostly used for vitamins or pediatric use
• Effervescent tablets – dissolve in water, common for supplements
• Sustained-release tablets – release medicine gradually over time

2. Capsules:
These are typically made using gelatin and are ideal for oils or substances sensitive to light and moisture.

• Hard gelatin capsules – often filled with powder
• Soft gelatin capsules – usually contain liquid or semi-solid content

Core Manufacturing Process

The typical production workflow includes:

1. Weighing & Blending
   First, active ingredients and excipients (like fillers or binders) are measured and mixed to ensure even distribution of the drug throughout the batch.
2. Granulation
   This step helps bind the powder particles together and makes them flow better in the machines. It improves how well tablets form and how they dissolve later.
3. Compression or Encapsulation
   Tablets are formed using high-pressure machines, while capsules are filled with powders or liquids using capsule-filling equipment.
4. Coating & Polishing
   Tablets are coated to make them smoother, control the release of the drug, or simply improve their appearance and taste. Capsules may be polished to remove dust and give them a glossy finish.
5. Packaging
   Final products are sealed in blister packs, plastic bottles, or foil strips, ready for distribution to hospitals, pharmacies, or retail stores.

Value Chain Snapshot

Here’s how the value chain typically flows:

APIs & Excipients (raw materials)
↓
Blending & Granulation
↓
Compression or Encapsulation
↓
Coating (if needed)
↓
Packaging & Labeling
↓
Distribution Channels (hospitals, retail, wholesalers)

This clean, structured process allows for efficiency, quality control, and the ability to scale up production as demand increases. As Nigeria continues to invest in health manufacturing zones and improve regulatory standards, MSMEs entering this space now have more support and clarity than ever before.

Current Market Demand & Trends (Nigeria & West Africa)

Nigeria’s pharmaceutical market is one of the biggest on the African continent, and it’s growing quickly. In 2024, the sector was valued at over $2 billion, and it’s expected to keep rising thanks to a mix of population growth, better awareness about health, and more people moving into cities. All of this adds up to more demand for medicines—especially affordable and accessible ones like tablets and capsules.

Why Demand is Growing

1. Heavy Reliance on Imports
Right now, over 70% of Nigeria’s medicines are imported from countries like India and China. This makes medicine prices more volatile and creates supply chain risks. The government now wants to reduce this reliance by encouraging local manufacturing. For new businesses, this means there’s space in the market and strong policy backing.

2. More People Managing Long-Term Conditions
Non-communicable diseases like hypertension, diabetes, and arthritis are becoming more common across both urban and rural areas. These require regular medication, which increases the demand for consistent, affordable supply of tablets and capsules—especially those used for daily maintenance.

3. Government & Regulatory Support
The National Agency for Food and Drug Administration and Control (NAFDAC) and other regulatory bodies have stepped up support for local drug production. From simplified licensing to tax breaks and grants in special economic zones, it’s now easier for MSMEs to enter this space with some level of official guidance and support.

4. Export Potential to West Africa
Nigeria doesn’t just make medicine for itself. It’s also a key hub for the West African pharmaceutical market, with countries like Ghana, Cameroon, and Côte d’Ivoire relying on Nigerian-made drugs. With the African Continental Free Trade Area (AfCFTA) beginning to smooth out regional trade barriers, manufacturers in Nigeria can now tap into a market of over 400 million people in West Africa alone.

Trend Area	Insights
Market Size (Nigeria)	Estimated at $2.1 billion in 2024 and projected to grow at 7–9% CAGR through 2030.
Import Dependence	Over 70% of pharmaceuticals are still imported, creating space for local production.
Chronic Disease Rise	Sharp rise in diabetes, hypertension, and infections increases daily medicine demand.
Urbanization Effect	Nigeria’s urban population exceeds 110 million; rising healthcare needs in urban centers.
Policy Push (NAFDAC)	Easier licensing, local sourcing incentives, and tax holidays for MSMEs in pharma sector.
Regional Market Access	Access to 15+ ECOWAS countries through AfCFTA; over 400 million people in reach.
Consumer Behavior Shift	Increased trust in locally manufactured generic drugs, especially post-COVID era.
Job Creation Potential	Sector can generate thousands of skilled and semi-skilled jobs, especially for youth.
Manufacturing Zones	Lekki Free Zone, Ogun Industrial Corridor supporting pharma clusters with infrastructure.
Export-Friendly Policies	Export financing, FX access, and reduced tariffs for licensed producers via NEPC & NEXIM.

Overall, the market is becoming more favorable for local production, especially in tablet and capsule manufacturing. Entrepreneurs who act now can benefit not only from rising demand within Nigeria but also from increasing opportunities to export to neighboring countries that lack strong pharma infrastructure.

ommon Applications & End-Use Sectors for Tablets & Capsules in Nigeria

Pharmaceutical tablets and capsules are essential across many sectors in Nigeria’s growing healthcare ecosystem. These solid dosage forms are not only convenient and stable, but they also make large-scale drug distribution easier—especially in regions with challenging logistics.

Here’s how these products are used in different segments:

1. Hospitals & Clinics
Public and private hospitals remain the largest consumers of prescription-based medications in Nigeria. Drugs like antibiotics, painkillers, and antihypertensives are in constant demand, especially for in-patient and emergency care. With over 30,000 registered healthcare facilities in the country, the need for consistent local supply is only growing.

2. Retail Pharmacies & Drug Shops
Over-the-counter and prescription tablets like paracetamol, malaria drugs, and vitamin supplements move in high volumes through community pharmacies. Nigeria has more than 10,000 registered retail pharmacy outlets nationwide, making this one of the most important retail distribution channels.

3. NGOs & Public Health Campaigns
Non-profits, donor-funded programs, and health agencies (like those running maternal and child health or malaria elimination projects) often purchase tablets and capsules in bulk. These include antibiotics, deworming drugs, and prenatal supplements. Many of these drugs are sourced locally to meet emergency or rural campaign needs more quickly.

4. Regional Export Distributors (ECOWAS Market)
Nigeria’s strategic position in West Africa allows it to serve as a pharmaceutical production hub for surrounding countries like Ghana, Benin, Niger, and Sierra Leone. Since most ECOWAS countries import over 80% of their medicines, local manufacturers in Nigeria can fill that gap—especially for affordable generics and basic essential drugs.

As local manufacturing gains more government support and access to funding improves, these end-use sectors are expected to grow significantly. The need for trusted, cost-effective medicine will only increase in the coming years—making tablets and capsules a smart product line for MSMEs entering the healthcare manufacturing space.

Business Setup Insights for Tablet & Capsule Manufacturing in Nigeria

Starting a pharmaceutical production unit for tablets and capsules in Nigeria requires careful planning, the right infrastructure, and compliance with health and safety laws. But thanks to growing local demand and regional export opportunities, it’s an attractive business idea for MSMEs and health-focused entrepreneurs.

Required Machinery

To run even a small or mid-sized production line, you’ll need machinery that helps with mixing, forming, packaging, and testing. Some commonly used equipment includes:

• Powder Mixers & Granulators: These help prepare the raw mix before it’s pressed into tablets or filled into capsules.
• Tablet Press Machines or Capsule Filling Machines: These are the core machines that actually form the final product.
• Coating Pans: Used for sugar or film coating to make tablets easier to swallow and protect their ingredients.
• Blister or Bottle Packaging Lines: Essential for wrapping up the final product for safe storage and transport.
• Quality Testing Equipment: Instruments like HPLC (High-Performance Liquid Chromatography), friability testers, and hardness testers ensure every batch meets health standards.

Most machines today are available in both semi-automatic and fully automatic versions, depending on your budget and manpower availability.

Raw Materials Needed

You’ll work with two main groups of materials:

• Active Pharmaceutical Ingredients (APIs) – These are the core drugs that treat the condition (like paracetamol or amoxicillin).
• Excipients – These include things like fillers, binders, disintegrants, and lubricants that help shape and stabilize the tablet or capsule.
• Gelatin or Plant-based Alternatives – Used for making capsule shells.
• Packaging Materials – Like PVC film, aluminum foil for blisters, plastic or glass bottles, and cartons.

Nigeria still imports a lot of its APIs from countries like India and China, but excipients and packaging are increasingly sourced locally.

Investment Overview (2024 Estimates)

Setup Element	Details
Facility Size	3,000 to 10,000 sq. ft. (can grow with volume)
Initial Workforce	10–50 people (based on automation level)
Utilities Needed	24/7 clean water supply, HVAC systems (for cleanrooms), and backup generators
Estimated Setup Cost	₦150 million to ₦500 million (~$100K–$350K), depending on capacity and tech

You’ll also need cleanroom sections for production and packaging to meet Good Manufacturing Practice (GMP) standards.

Ideal Locations in Nigeria

Here are some strategic places to consider for your unit:

• Lagos – Nigeria’s commercial hub with direct access to ports, skilled workers, and a large market.
• Ogun State – Home to many industrial clusters and offers tax incentives for manufacturing.
• Anambra – A growing pharmaceutical and health-tech zone with strong market demand and state support.

All these locations have industrial parks and access to transport routes, which can help in both sourcing raw materials and distributing products.

Licensing & Compliance Requirements

To legally operate in Nigeria’s pharmaceutical space, you must follow strict regulations and get approvals from key bodies:

• NAFDAC: You must obtain both a manufacturing license and product registration for every medicine.
• Pharmacists Council of Nigeria (PCN): Your company must be supervised by licensed pharmacists and registered with PCN.
• GMP Compliance: Good Manufacturing Practice (GMP) certification ensures product quality and hygiene standards.
• Environmental & Fire Safety: You’ll need inspection and clearance from local authorities for pollution control, waste disposal, and fire preparedness.

These approvals may take time, so it’s good to begin the process early – preferably while your facility is being built or renovated.

Setting up a tablet and capsule plant in Nigeria is a big step, but it’s becoming increasingly doable—especially for well-prepared MSMEs. If you focus on quality, regulatory compliance, and strategic location, this business can become both profitable and impactful in improving healthcare access locally and across West Africa.

Government Support & Export Opportunities for MSMEs in Nigeria

If you’re planning to set up a tablet or capsule manufacturing unit in Nigeria, there’s good news — several government-backed programs and institutions are actively supporting MSMEs, especially in the health and pharmaceutical sectors. These supports can help ease your startup journey, reduce initial investment pressure, and even open up international markets.

Key Support Initiatives

Here’s how different government organizations are offering real support:

1. Nigerian Export Promotion Council (NEPC)

The NEPC plays a major role in helping local manufacturers get into the export market. If your pharma products meet regulatory standards, you can join their Export Expansion Facility Programme (EEFP), which offers grants and technical support to small businesses. They also run training sessions on export documentation, packaging standards, and foreign market access — especially useful for businesses targeting ECOWAS and other African countries.

2. Bank of Industry (BoI)

The Bank of Industry is one of the most MSME-friendly lenders in Nigeria. For tablet and capsule manufacturers, BoI offers special loans that cover:

• Equipment financing for production lines
• Working capital to keep the business running in early stages
• Support for technology upgrades or expansion

In many cases, interest rates are lower than what’s available from commercial banks, and repayment terms are designed to be flexible.

3. NAFDAC (National Agency for Food and Drug Administration and Control)

Beyond its regulatory role, NAFDAC has made moves in recent years to streamline licensing and product registration processes for local manufacturers. Through digital applications and simplified procedures, they’re reducing wait times and making it easier for MSMEs to enter the market legally. As of 2024, small-scale producers benefit from faster inspections and a “fast-track” review system if you’re part of certain government-led clusters or innovation zones.

4. Federal Ministry of Industry, Trade, and Investment

This ministry runs several schemes aimed at industrial development and import substitution. One such effort is the Nigeria Industrial Revolution Plan (NIRP), which puts a strong emphasis on pharmaceutical self-sufficiency. Under this umbrella, MSMEs can access:

• Land in government-supported industrial parks
• Tax relief under pioneer status for new industries
• Access to government procurement contracts if producing essential drugs

They also coordinate with state-level programs for ease of doing business and sector-specific investment promotion.

Export Opportunities

With Nigeria’s strategic location and ECOWAS membership, your business isn’t limited to local sales. There’s a growing demand for quality generics in neighboring countries like Ghana, Niger, and Sierra Leone, where local production is limited.

Exporting also becomes easier with support from:

• The Export Development Fund (EDF) – Available through NEPC to help cover costs related to foreign certifications, international exhibitions, and logistics.
• AfCFTA (African Continental Free Trade Area) – Offers tariff reductions and smoother cross-border movement for goods, which is a big plus for pharma companies.

As the global supply chain shifts post-pandemic, buyers are also looking for new sources from Africa. If your facility meets WHO prequalification or similar standards, you can tap into international donor-funded supply chains as well.

Nigeria’s pharmaceutical sector is being actively encouraged at both the state and federal levels. With the right licenses, funding, and export focus, MSMEs can build successful ventures that supply both domestic and regional health markets.

Challenges and Practical Tips for Entrepreneurs

Starting a pharmaceutical business in Nigeria — especially one focused on making tablets and capsules — can be rewarding, but it’s not without its hurdles. While the market demand is strong and the government is supportive, entrepreneurs need to be prepared for a few real-world challenges that come with manufacturing in this sector.

Common Challenges

1. Regulatory Delays
Getting approval from NAFDAC can sometimes take longer than expected. While application systems have improved, bottlenecks still happen — especially when it comes to product registration, factory inspection, and meeting documentation requirements. This can push your launch timeline further than planned if you’re not ready with all compliance materials upfront.

2. Limited Access to APIs (Active Pharmaceutical Ingredients)
Nigeria currently imports the vast majority of its APIs, mainly from India and China. This means that delays in global shipping, currency fluctuations, or port clearance issues can cause interruptions in your production. There’s limited local API production, so you’re reliant on international suppliers — and that requires solid planning and relationships.

3. Risk of Counterfeit Products in Market
Unfortunately, Nigeria’s pharmaceutical market still battles with counterfeit drugs. If you’re a new brand, building customer trust can be tough — especially if lookalike products enter the market. Counterfeiting doesn’t just affect big brands; it damages credibility across the entire industry and creates doubt among consumers.

Practical Tips for First-Time Entrepreneurs

1. Work with Trusted API Suppliers
Instead of relying on random importers, find reputable API sources through trade networks, pharmaceutical associations, or platforms recommended by NAFDAC. Long-term supply contracts with credible partners can also help you manage price stability and availability.

2. Invest in Basic Digitization
Even small to mid-scale manufacturers can benefit from using software tools for batch tracking, raw material inventory, and expiry date alerts. It’s not about high-end automation — even simple digital dashboards or spreadsheets can prevent costly errors and improve traceability.

3. Pursue Quality Certifications
Getting GMP certification and other quality seals not only satisfies regulators — it also sends a clear message to buyers, hospitals, and distributors that your products are genuine. You can even join voluntary programs that issue QR codes or digital authentication to your packaging to fight counterfeits.

4. Build Relationships With Regulators Early
Rather than waiting till the last minute, engage NAFDAC and the Pharmaceutical Council early in your setup process. Ask questions, clarify document requirements, and align your facility layout with compliance needs — this reduces friction during inspections.

5. Don’t Skip Branding & Packaging
At launch, make sure your product packaging is professional and tamper-proof. Clear labeling, dosage instructions, and security seals go a long way in setting your brand apart — especially in a market where trust in medication is a real concern.

The pharmaceutical sector in Nigeria has solid opportunities — but success depends on preparation, product quality, and staying on top of regulatory changes. MSMEs that invest early in trust, partnerships, and basic systems are more likely to grow steadily and avoid the common pitfalls many first-time manufacturers face.

Future Potential of This Industry in Nigeria

The outlook for Nigeria’s tablet and capsule manufacturing sector is strong — not just because of today’s demand, but because of the structural shifts that are shaping the future. From government-led initiatives to advancements in local research and tech adoption, this industry is entering a phase where local production can meet a much larger share of national and regional needs.

1. Local R&D is Getting Stronger

More Nigerian universities and pharmaceutical research bodies are beginning to focus on developing locally relevant drug formulations. For example:

• Institutions like the University of Lagos, Ahmadu Bello University, and NIPRD (National Institute for Pharmaceutical Research and Development) are conducting studies on tropical disease treatments, herbal drug standardization, and low-cost formulations tailored to Nigerian health needs.
• This trend is helping create intellectual property and product pipelines that MSMEs can commercialize through local manufacturing — reducing dependence on foreign brands and high-cost imports.

These local innovations don’t just reduce import bills — they’re also designed to better suit the lifestyle, metabolism, and common conditions of Nigerian populations.

2. Technology Adoption is Accelerating

Though Nigeria’s pharma sector was previously slow to adopt technology, 2024–2025 shows a shift toward smarter, tech-enabled production. Here’s what’s happening:

• Some plants are piloting IoT (Internet of Things) sensors for monitoring humidity, temperature, and air quality in cleanrooms — which are essential for tablet/capsule quality.
• AI-based quality control systems are being explored for rapid inspection of coating uniformity, tablet size, and packaging integrity. These systems reduce manual errors and improve output consistency.
• Even MSMEs can now afford basic digital tools for inventory control, batch traceability, and production forecasting.

This wave of affordable tech is lowering the entry barrier for new manufacturers and making operations smoother and more compliant.

3. Decentralized Manufacturing is on the Rise

One of the most exciting shifts is the move toward modular and distributed production units. Here’s what that means:

• Instead of building massive plants in urban centers only, companies are starting to explore modular pharma setups that can be installed in Tier-2 and Tier-3 towns.
• These setups typically require 3,000–5,000 sq. ft. of space, consume less power, and can produce targeted formulations for nearby hospitals or state health programs.
• This rural or semi-urban expansion opens up job creation, improves medicine availability in under-served regions, and reduces logistics costs.

For entrepreneurs, this trend is a game-changer. It allows smaller businesses to tap into local demand without the overhead of a Lagos-scale operation.

4. Government Procurement is Favoring Local Producers

As of 2024, the Nigerian government has increased its commitment to buying from local pharmaceutical manufacturers for public health needs. This includes:

• National immunization drives, school health programs, and essential medicines kits for primary healthcare centers across the country.
• The National Drug Policy 2021–2030 clearly mentions localization of pharmaceutical production as a national goal.
• More tenders and contracts are being awarded to companies with local production facilities — including MSMEs that meet basic GMP and NAFDAC compliance.

This kind of steady institutional demand is a strong long-term revenue source for small manufacturers who can meet basic quality and volume requirements.

5. Regional Market Expansion is Viable

Nigeria’s pharma exports to ECOWAS and Central Africa are still small compared to potential — but that’s changing:

• The AfCFTA (African Continental Free Trade Area) agreement is reducing export duties, making it easier for Nigerian manufacturers to export to countries like Ghana, Liberia, and Cameroon.
• Many West African nations still rely heavily on imports for up to 80–90% of their medication supply, and Nigeria is geographically and economically well-positioned to fill this gap.

By 2025, more Nigerian pharma units are expected to receive WHO-GMP or regional certifications, enabling cross-border sales at scale.

Whether you’re an aspiring manufacturer or an MSME looking to diversify, this industry offers scalable, high-impact opportunities for the future:

• Entry costs are lower than before, especially with modular plants and financing support.
• Local innovation is maturing, giving you access to unique formulations.
• Government demand and regional exports are growing — which means more consistent cash flow possibilities.
• Tech tools are now affordable and available, even for small-scale manufacturers.

If you’re thinking long-term, starting now means you’ll be well-positioned to lead when the full momentum hits between 2026 and 2030.

Conclusion

Setting up a tablet and capsule manufacturing unit in Nigeria is not only a viable business idea but also a nation-building opportunity. With the right planning, equipment, and regulatory compliance, MSMEs and entrepreneurs can make a meaningful impact in healthcare and economic development. The sector offers room for innovation, export growth, and long-term profitability.

References

Website URL	Organization Name
https://www.nafdac.gov.ng	National Agency for Food and Drug Administration and Control (NAFDAC)
https://www.pcn.gov.ng	Pharmacists Council of Nigeria (PCN)
https://www.boi.ng	Bank of Industry (BoI)
https://nepc.gov.ng	Nigerian Export Promotion Council (NEPC)
https://niprd.gov.ng	National Institute for Pharmaceutical Research and Development (NIPRD)
https://www.fmard.gov.ng	Federal Ministry of Agriculture and Rural Development (for plant-based APIs)
https://www.trade.gov.ng	Federal Ministry of Industry, Trade and Investment
https://www.health.gov.ng	Federal Ministry of Health
https://www.smedan.gov.ng	Small and Medium Enterprises Development Agency of Nigeria (SMEDAN)
https://www.customs.gov.ng	Nigeria Customs Service (for import/export regulations)

Frequently Asked Questions